|
|
|
| Changes and Clinical Significance of Serum BGP and AKP Levels in Patients with Diabetes Mellitus before and after Artificial Dental Implant Restoration |
| XU Haifeng, et al |
| Dalian Second People’s Hospital, Liaoning Dalian 116011, China |
|
|
|
|
Abstract Objective: To explore the changes and clinical significance of serum osteocalcin (BGP) and alkaline phosphatase (AKP) levels in patients with diabetes mellitus (DM) before and after artificial dental implant restoration. Methods: A total of 106 patients with DM who underwent artificial dental implant restoration from June 2014 to June 2017 were selected for the study. According to the glycemic control, they were divided into glycemic control group (n=66) and poor glycemic control group (n=40). And 50 healthy people with artificial dental implant restoration treated in the same period were selected as control group. The levels of BGP and AKP in each group were evaluated before operation and at 6 months after operation, and the probing depth (PD) and depth of bone loss (DSB) were compared at 6 months after operation and at 1 year after operation. The incidence rate of inflammation around implant was recorded. Results: The levels of BGP and AKP in glycemic control group and poor glycemic control group at each time point were higher than those in control group (P<0.05). Thelevels of BGP and AKP were increased first and then decreased at the time period from before operation to 1 year after operation in glycemic control group and poor glycemic control group (P<0.05), and thelevels of BGP and AKP in poor glycemic control group at each time point were higher than those in glycemic control group (P<0.05), and there were no interactions of different groups and time in the BGP and AKP (P>0.05). The PD level at 1 year after operation was higher than that at 6 months after operation in glycemic control group and poor glycemic control group (P<0.05), and there was no significant difference in control group between at 6 months after operation and at 1 year after operation (P>0.05), and the difference between the two time points in poor glycemic control group was higher than that in glycemic control group and control group (P<0.05), and the difference between the two time points in glycemic control group was higher than that in control group (P<0.05). At 1 year after operation, the DSB levels in the three groups were higher than those at 6 months after operation (P<0.05), and the difference between the two time points in poor glycemic control group was higher than that in glycemic control group and control group (P<0.05), and the difference between the two time points in glycemic control group was higher than that in control group (P<0.05). The incidence rate of inflammation around implant in poor glycemic control group was higher than that in glycemic control group and control group (P<0.05), and there was no significant difference in the incidence rate of inflammation around implant between glycemic control group and control group (P>0.05). Conclusion: DM can have a variety of negative effects on dental implants. DM patients should actively control blood glucose after dental implant surgery so as to improve the prognosis of dental implants.
|
|
|
|
|
|
[1] 竹娜,曹庆堂,王宏远.平台转换设计在人工种植牙临床应用现状与前景[J].口腔颌面修复学杂志,2018,19(2):124~128.
[2] 黄舒啸,陈栋,刘磐,等.老年2型糖尿病患者血糖水平对种植牙状态的影响[J].江苏医药,2018,44(4):372~374.
[3] 周雨田,李小惠,陈果,等.高龄COPD患者稳定期长期吸入激素对骨密度的影响[J].西部医学,2018,30(5):732~734.
[4] 汪梦洁,毛拓华,李竞,等.武汉大学人民医院住院2型糖尿病患者骨密度及其影响因素[J].职业与健康,2018,34(8):1075~1078,1082.
[5] 柯文才,武强,顾云霞.老年2型糖尿病患者骨代谢标志物与骨密度的相关性分析[J].检验医学,2017,32(2):86~89.
[6] 金晓华,冯剑颖,张剑,等.慢性牙周炎及吸烟对后牙局部种植义齿修复患者种植体周围炎发生的影响[J].中华医院感染学杂志,2018,28(9):1398~1400.
[7] 金鑫,吴飞妮,陈海波,等.2型糖尿病患者骨碱性磷酸酶25羟维生素D及骨钙素水平[J].贵州医科大学学报,2017,42(9):1111~1113,1116. |
|
|
|
2019, Vol. 25 
